Related Experiment Video
Updated: Aug 21, 2026

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
Published on: September 21, 2021
Executive Summary for The Society of Thoracic Surgeons (STS) / World Society for Pediatric and Congenital Heart
Jennifer S Nelson1, Awais Ashfaq2, James D St Louis3
1Department of Cardiovascular Services, Nemours Children's Hospital, Orlando, Florida, USA.
Insights
Pulmonary valve replacement (PVR) is crucial for repaired Tetralogy of Fallot (TOF) patients. Guidelines now offer an updated framework for PVR timing, considering symptoms, heart function, and risks.
Area of Science:
- Cardiology
- Congenital Heart Surgery
- Pediatric Cardiology
Background:
- Pulmonary valve replacement (PVR) is a critical intervention for patients with repaired Tetralogy of Fallot (TOF) experiencing significant pulmonary regurgitation.
- Existing guidelines require an update to reflect current evidence and consensus on PVR timing and indications.
Purpose of the Study:
- To summarize consensus-based recommendations from three multi-societal documents regarding PVR in repaired TOF.
- To provide an updated framework for clinical decision-making on PVR timing, indications, and options.
Main Methods:
- Synthesis of evidence-based Clinical Practice Guidelines (CPG), Expert Consensus Documents (ECD), and Expert Opinion ("White Paper").
- Collaboration between The Society of Thoracic Surgeons (STS), The World Society for Pediatric and Congenital Heart Surgery (WSPCHS), and The European Congenital Heart Surgeons Association (ECHSA).
Main Results:
- Key decision-making factors for PVR include symptom status, ventricular volumes and function, and procedural risks.
- Emerging evidence supports tailored intervention strategies for PVR in repaired TOF patients.
Conclusions:
- The summarized documents offer a comprehensive framework for PVR decision-making in repaired TOF.
- Future research should compare transcatheter versus open surgical PVR outcomes, especially in pediatric and adolescent populations.
Abstract:
Pulmonary valve replacement (PVR) is a common and critical intervention for patients with repaired tetralogy of Fallot (TOF) and clinically significant pulmonary regurgitation. The Society of Thoracic Surgeons (STS) collaborated with The World Society for Pediatric and Congenital Heart Surgery (WSPCHS) and The European Congenital Heart Surgeons Association (ECHSA) to produce three multi-societal evidence-based manuscripts: (1) Clinical Practice Guidelines (CPG) on Indications and Timing of Pulmonary Valve Replacement in Repaired Tetralogy of Fallot; (2) Expert Consensus Document (ECD) on Timing, Indications, and Options for Pulmonary Valve Replacement in Children with Repaired Tetralogy of Fallot; and (3) Expert Opinion ("White Paper") on The Role of Exercise Testing in Determining Optimal Timing of Pulmonary Valve Replacement in Tetralogy of Fallot. The purpose of this Executive Summary is to summarize the associated consensus-based recommendations from the CPG, consensus-based statements from the ECD, and consensus-based expert opinions from the "White Paper". This collection of documents provides an updated framework for decision-making about PVR for patients with repaired TOF. Key considerations include the status of symptoms, ventricular volumes and function, and procedural risks, with emerging evidence supporting tailored strategies of intervention. Future research should focus on comparing timing and long-term outcomes for transcatheter versus open surgical PVR, particularly in pediatric and adolescent populations.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Stenosis IV: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy

